News
3d
Pharmaceutical Technology on MSNChina’s NMPA authorises Santen’s glaucoma treatment applicationChina’s National Medical Products Administration (NMPA) has approved the marketing authorisation application of Santen ...
Topical ocular prostaglandin use was also not associated ... Conclusions Our results confirmed an association between ED and glaucoma that cannot be attributed to topical BB use.
On the plus side, the Mont Blanc trial of the drug showed that it was as effective in treating the eye disease as prostaglandin analogue latanoprost 0.005%, a standard therapy for glaucoma ...
The prevalence of glaucoma is increasing all over the world, ophthalmic surgeon Moemen Elnawawy told 100% Optical attendees ...
Historically, drops have been first-line therapy for glaucoma. We would typically start patients on a prostaglandin analog, and if we do not achieve our target pressure within a few months or if ...
Purpose: We investigated the intraocular pressure (IOP) variations after switching from 0.005% latanoprost to 0.01% bimatoprost in open-angle glaucoma patients who experienced IOP elevation during ...
Are you searching for effective medications to treat 'Glaucoma'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential for 'managing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results